Cargando…

Calcium Deregulation: Novel Insights to Understand Friedreich’s Ataxia Pathophysiology

Friedreich’s Ataxia (FRDA) is a neurodegenerative disorder, characterized by degeneration of dorsal root ganglia, cerebellum and cardiomyopathy. Heart failure is one of the most common causes of death for FRDA patients. Deficiency of frataxin, a small mitochondrial protein, is responsible for all cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abeti, Rosella, Brown, Alexander F., Maiolino, Marta, Patel, Sandip, Giunti, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176067/ https://www.ncbi.nlm.nih.gov/pubmed/30333728 http://dx.doi.org/10.3389/fncel.2018.00264

Ejemplares similares

Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich’s Ataxia Models
por: Abeti, Rosella, et al.
Publicado: (2018)

Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia
por: Zeitlberger, Anna M., et al.
Publicado: (2018)

Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare
por: Al-Mahdawi, Sahar, et al.
Publicado: (2018)

'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'
por: Abeti, R, et al.
Publicado: (2016)

Friedreich's Ataxia Frequency in a Large Cohort of Genetically Undetermined Ataxia Patients
por: Brown, Alexander F., et al.
Publicado: (2021)

Auditory Phenotypic Variability in Friedreich’s Ataxia Patients
por: Koohi, Nehzat, et al.
Publicado: (2021)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Identification of telomere dysfunction in Friedreich ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015)

Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
por: Boesch, Sylvia, et al.
Publicado: (2019)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
por: Mercado-Ayón, Elizabeth, et al.
Publicado: (2022)

Iron in Friedreich Ataxia: A Central Role in the Pathophysiology or an Epiphenomenon?
por: Alsina, David, et al.
Publicado: (2018)

Onset features and time to diagnosis in Friedreich’s Ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2020)

Prediction of the disease course in Friedreich ataxia
por: Hohenfeld, Christian, et al.
Publicado: (2022)

The Role of Iron in Friedreich’s Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models
por: Llorens, José Vicente, et al.
Publicado: (2019)

Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation
por: Rodden, Layne N., et al.
Publicado: (2021)

Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)
por: Lynch, David R., et al.
Publicado: (2020)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Urinary, bowel and sexual symptoms in a cohort of patients with Friedreich’s ataxia
por: Lad, Meher, et al.
Publicado: (2017)

Cerebrospinal Fluid Proteomics in Friedreich Ataxia Reveals Markers of Neurodegeneration and Neuroinflammation
por: Imbault, Virginie, et al.
Publicado: (2022)

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
por: Lynch, David R., et al.
Publicado: (2018)

Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions
por: Lynch, David R., et al.
Publicado: (2021)

Complexity of the Genetics and Clinical Presentation of Spinocerebellar Ataxia 17
por: Nethisinghe, Suran, et al.
Publicado: (2018)

Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich’s Ataxia
por: Vavla, Marinela, et al.
Publicado: (2020)

Bone Mineral Density and Current Bone Health Screening Practices in Friedreich’s Ataxia
por: Dunn, Julia, et al.
Publicado: (2022)

Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023)

Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany
por: Giunti, Paola, et al.
Publicado: (2013)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Two Cases of Friedreich’s Ataxia
por: Stephenson, F. H.
Publicado: (1897)

Respiratory Function in Friedreich’s Ataxia
por: Vinante, Elena, et al.
Publicado: (2022)

Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich’s Ataxia
por: Soragni, Elisabetta, et al.
Publicado: (2015)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
por: Cissé, Cheick A. K., et al.
Publicado: (2021)

A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models
por: Abeti, Rosella, et al.
Publicado: (2022)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
por: Niewiadomska-Cimicka, Anna, et al.
Publicado: (2020)

Functional and Structural Brain Damage in Friedreich's Ataxia
por: Vavla, Marinela, et al.
Publicado: (2018)

Anaesthesia for a patient with Friedreich's ataxia
por: Ganesan, Ilango
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9a4c968c7k7h458bnuh9c2lbb2